These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1868443)

  • 21. Rho exchange factor ECT2 is induced by growth factors and regulates cytokinesis through the N-terminal cell cycle regulator-related domains.
    Saito S; Tatsumoto T; Lorenzi MV; Chedid M; Kapoor V; Sakata H; Rubin J; Miki T
    J Cell Biochem; 2003 Nov; 90(4):819-36. PubMed ID: 14587037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
    Eager KB
    Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated expression of c-myc proto-oncogene in scleroderma fibroblasts.
    Trojanowska M; Wu LT; LeRoy EC
    Oncogene; 1988 Oct; 3(4):477-81. PubMed ID: 3078955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of nerve growth factor responsiveness in C6-2B glioma cells by expression of trkA proto-oncogene.
    Colangelo AM; Fink DW; Rabin SJ; Mocchetti I
    Glia; 1994 Oct; 12(2):117-27. PubMed ID: 7868185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic induction of protooncogene expression in gerbil brain.
    Kindy MS; Carney JP; Dempsey RJ; Carney JM
    J Mol Neurosci; 1991; 2(4):217-28. PubMed ID: 1905565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the expression of the c-fos proto-oncogene in the rat cerebral cortex during learning].
    Maleeva NE; Ivolgina GL; Anokhin KV; Limborskaia SA
    Genetika; 1989 Jun; 25(6):1119-21. PubMed ID: 2509287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli.
    Grumont RJ; Gerondakis S
    Oncogene Res; 1990; 5(4):245-54. PubMed ID: 2204017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of a mcf.2 oncogene by deletion of amino-terminal coding sequences.
    Noguchi T; Galland F; Batoz M; Mattei MG; Birnbaum D
    Oncogene; 1988 Dec; 3(6):709-15. PubMed ID: 2577874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA; Avila MA; Notario V
    Oncogene; 1999 Jan; 18(3):689-701. PubMed ID: 9989819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells.
    Ron D; Tronick SR; Aaronson SA; Eva A
    EMBO J; 1988 Aug; 7(8):2465-73. PubMed ID: 3056717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell transformation by dbl oncogene.
    Zangrilli D; Eva A
    Methods Enzymol; 1995; 256():347-58. PubMed ID: 7476452
    [No Abstract]   [Full Text] [Related]  

  • 37. The predicted DBL oncogene product defines a distinct class of transforming proteins.
    Eva A; Vecchio G; Rao CD; Tronick SR; Aaronson SA
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2061-5. PubMed ID: 3281159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation.
    Notario V; Gutkind JS; Imaizumi M; Katamine S; Robbins KC
    J Cell Biol; 1989 Dec; 109(6 Pt 1):3129-36. PubMed ID: 2687293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The myc family of nuclear proto-oncogenes.
    Lee WM
    Cancer Treat Res; 1989; 47():37-71. PubMed ID: 2577005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dbl expression driven by the neuron specific enolase promoter induces tumor formation in transgenic mice with a p53(+/-) genetic background.
    Colucci-D'Amato GL; Santelli G; D'Alessio A; Chiappetta G; Mineo A; Manzo G; Vecchio G; de Franciscis V
    Biochem Biophys Res Commun; 1995 Nov; 216(3):762-70. PubMed ID: 7488191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.